MedPath

ECLYPIA

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

SKAMo-1: Characterization of the Upper Layers of Skin

Not Applicable
Completed
Conditions
Diabetes
First Posted Date
2023-09-21
Last Posted Date
2023-09-21
Lead Sponsor
Eclypia
Target Recruit Count
14
Registration Number
NCT06044532
Locations
🇫🇷

CHU Grenoble Alpes, Grenoble, France

SKAMo-2: the Real-life Test of Continuous Photoacoustic Signal by Neogly in Patients With Type I Diabetes

Not Applicable
Recruiting
Conditions
Diabetes
First Posted Date
2023-09-13
Last Posted Date
2023-09-13
Lead Sponsor
Eclypia
Target Recruit Count
10
Registration Number
NCT06035367
Locations
🇫🇷

CHU Grenoble Alpes, Grenoble, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.